CHIAZOR ROBIN-NGBOR: Open Payments
NPI 1982462446 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$318 in 5 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $318
Food & beverage: $318
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $175 |
| Teva Pharmaceuticals USA, Inc. | 1 | $116 |
| ACADIA Pharmaceuticals Inc | 1 | $27 |
Products named: INGREZZA, AUSTEDO XR, NUPLAZID.
Industry payments across TX — which companies pay providers there.
